Besides this, the higher level of PSMD3 mRNA predicts a worse prognosis of acute myeloid leukemia patients, and PSMD3 promotes the progression of chronic myeloid leukemia by stabilizing NF-kB (38, 39). This evidence concerns the gene NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive.